arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Pennant Group, Inc.

PNTG
$38.99 ▼ -0.03 (-0.06%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
32 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Neutral
auto_awesome

Analytical Summary

Pennant Group, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.4B
Dividend Yield
Revenue Growth 36.0%
Op. Margin 6.1%
ROIC 7.7%
FCF / Share $-0.25
Trailing P/E 156.0x
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

32-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$285.36M
↑ +36.0%
Net Income Profit after all expenses
$8.52M
↑ +9.6%
Operating Margin Operating profit as % of sales
6.1%
— +0.4% 44th
FCF / Share Free cash flow per share
$-0.25
↑ +62.9%
Long-Term Debt Long-term obligations
$164.67M
↓ -2.5%

Health Breakdown

Profitability
42
Financial Health
83
Cash Quality
73

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 32 quarters